Novel N-phenyl dichloroacetamide derivatives as anticancer reagents: design, synthesis and biological evaluation.
Yongchong Yang, Peihua Shang, Changmei Cheng, Dongchun Wang, Ping Yang, Feng Zhang, Tianwen Li, Aijun Lu, Yufen Zhao
Index: Eur. J. Med. Chem. 45 , 4300-6, (2010)
Full Text: HTML
Abstract
A current study shows that sodium dichloroacetate (DCA) can induce cancer cell apoptosis and inhibit tumor growth, but its cytotoxic activity is low (IC(50) > 1000 microM for A549). In this paper, a variety of DCA derivatives were synthesized, and their cytotoxic activities were evaluated. The result showed that the N-phenyl-2,2-dichloroacetamide analogues had satisfactory potencies. Among them, N-(3-iodophenyl)-2,2-dichloroacetamide (3e), an optimized lead compound, has an IC(50) against A549 as low as 4.76 microM. Furthermore, it can induce cancer cell apoptosis and has a low toxicity in mice (LD(50) = 1117 mg/kg).2010 Elsevier Masson SAS. All rights reserved.
Related Compounds
Related Articles:
Dual-targeting of aberrant glucose metabolism in glioblastoma.
2015-01-01
[J. Exp. Clin. Cancer Res 34 , 14, (2015)]
2006-10-01
[J. Korean Med. Sci. 21 , 800-4, (2006)]
Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism.
2015-08-01
[Mol. Cancer Ther. 14 , 1794-804, (2015)]
2014-01-01
[J. Transl. Med. 12 , 247, (2014)]
2011-01-01
[BMC Cancer 11 , 235, (2011)]